InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Mitchell Stephen Ray, Director. Insider active across 1 company, notably Vanda Pharmaceuticals Inc.. In total, 11 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €113k. Activity tracked since 10 June 2021. The latest transaction was disclosed on 13 June 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mitchell Stephen Ray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
7,000 shares@ US$4.5913.8% of flowCommon StockSEC:0000950170-25-087025:0
59,225 shares0Common StockSEC:0000950170-25-083890:0
5,000 shares@ US$5.17269.3% of flowCommon StockSEC:0000950170-24-128115:0
20,529 shares0Common StockSEC:0000950170-24-063017:0
6,500 shares@ US$6.053713.7% of flowCommon StockSEC:0001209191-23-045447:0
17,307 shares0Common StockSEC:0001209191-23-036285:0
12,006 shares0Common StockSEC:0001209191-22-038448:0
2,700 shares@ US$9.47890.0065% mcap12.2% of flowCommon StockSEC:0001209191-22-036835:0
5,985 shares@ US$10.5726.6% of flowCommon StockSEC:0001209191-21-055685:0
4,015 shares@ US$10.5717.4% of flowCommon StockSEC:0001209191-21-041496:0
5,000 shares0Common StockSEC:0001209191-21-040240:0
11 of 11 declarations
About Mitchell Stephen Ray
Mitchell Stephen Ray is a Director at Vanda Pharmaceuticals Inc. (XNAS). He has 11 filings in total, and across the sampled recent filings between 2021-06-14 and 2025-06-16, sells total EUR 112584 and the most frequent transaction nature is Attribution.
